Glucose-Powered Ultrasmall Chemotactic Nanorobots for Retinal Degeneration Treatment
Retinal degeneration poses a growing global health challenge with limited effective treatments. Current options, such as intravitreal injections of therapeutic drugs, are severely constrained by the vitreous humor barrier, a dense, gel-like matrix that limits drug diffusion to the retina. Micro/nanorobots with active propulsion have emerged as promising platforms for targeted drug delivery to overcome …
Glucose-Powered Ultrasmall Chemotactic Nanorobots for Retinal Degeneration Treatment Read More »
